FENC FY 2024 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

FENCFennec Pharmaceuticals Inc.

$220M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$48M+123.7% YoY

Gross Profit

$44M93.3% margin

Operating Income

$3M5.4% margin

Net Income

-$436,000-0.9% margin

EPS (Diluted)

$-0.02

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

$27M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$45M

Total Liabilities

$51M

Stockholders' Equity

-$6M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$21M	+123.7%
Gross Profit	$44M	$20M	+121.8%
Operating Income	$3M	-$13M	+120.1%
Net Income	-$436,000	-$16M	+97.3%